TLR4 and cancer: Active TLR4 signaling, initially identified in breast cancer cells, has been implicated in the chronic inflammation-mediated development of different cancers, cancer progression, chemotherapeutic resistance, cancer cell stemness, invasion, metastasis, and disease relapse [95, 99–102].